Genmab A/S (GMAB) News Today

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)

$28.33

-0.20 (-0.70%)

(As of 04/18/2024 ET)

Source

Source	Headline
	Genmab A/S (NASDAQ:GMAB) Shares Gap Down to $29.43 marketbeat.com - April 17 at 11:37 AM
	Genmab A/S: Genmab Announces Net Sales of DARZALEX (daratumumab) for First Quarter of 2024 finanznachrichten.de - April 16 at 8:05 AM
	Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2024 globenewswire.com - April 16 at 6:24 AM
	Transactions in Connection with Share Buy-back Program Genmab globenewswire.com - April 15 at 4:07 AM
	Short Interest in Genmab A/S (NASDAQ:GMAB) Increases By 17.1% marketbeat.com - April 14 at 7:21 PM
	Genmab A/S (NASDAQ:GMAB) Shares Acquired by NewEdge Wealth LLC marketbeat.com - April 14 at 6:57 AM
	Genmab A/S (NASDAQ:GMAB) Given Average Rating of "Hold" by Brokerages americanbankingnews.com - April 14 at 3:00 AM
	Genmab A/S (NASDAQ:GMAB) Given Consensus Rating of "Hold" by Brokerages marketbeat.com - April 14 at 2:27 AM
	Genmab A/S (NASDAQ:GMAB) Stake Trimmed by Hardman Johnston Global Advisors LLC marketbeat.com - April 12 at 9:38 PM
	Transactions in Connection with Share Buy-back Program globenewswire.com - April 8 at 5:44 AM
	Brokers Offer Predictions for Genmab A/S's FY2025 Earnings (NASDAQ:GMAB) marketbeat.com - April 8 at 2:33 AM
	185,698 Shares in Genmab A/S (NASDAQ:GMAB) Acquired by ANTIPODES PARTNERS Ltd marketbeat.com - April 5 at 4:53 PM
	Genmab A/S (NASDAQ:GMAB) Expected to Earn Q2 2024 Earnings of $0.28 Per Share marketbeat.com - April 5 at 8:22 AM
	Genmab Stock (NASDAQ:GMAB), Quotes and News Summary benzinga.com - April 5 at 8:08 AM
	Genmab A/S (NASDAQ:GMAB) Shares Gap Up to $29.30 marketbeat.com - April 4 at 1:20 PM
	Genmab Buys Ovarian Cancer Drug Developer for $1.8 Billion msn.com - April 3 at 7:18 PM
	ProfoundBio to be acquired by Danish biotech giant Genmab for $1.8 billion bizjournals.com - April 3 at 7:18 PM
	Genmab A/S (NASDAQ:GMAB) Shares Gap Down to $29.96 marketbeat.com - April 3 at 2:54 PM
	M&A News: Genmab (NASDAQ:GMAB) Is Acquiring ProfoundBio for $1.8B msn.com - April 3 at 2:18 PM
	Genmab Takes The Next Step In Its 'Evolution' With A $1.8 Billion Takeover finance.yahoo.com - April 3 at 2:18 PM
	Genmab Buys ProfoundBio for $1.8B to Boost Oncology Portfolio investopedia.com - April 3 at 9:20 AM
	Genmab to purchase US-based biotech company ProfoundBio for $1.8 billion in all-cash deal msn.com - April 3 at 9:18 AM
	Genmab Strengthens Oncology Portfolio With $1.8 Bln Acquisition of ProfoundBio finance.yahoo.com - April 3 at 9:18 AM
	Denmark's Genmab to acquire ProfoundBio for $1.8 billion reuters.com - April 3 at 3:47 AM
	Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio businesswire.com - April 3 at 1:35 AM
	Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio globenewswire.com - April 3 at 1:34 AM
	Short Interest in Genmab A/S (NASDAQ:GMAB) Grows By 10.2% marketbeat.com - April 2 at 10:00 AM
	Transactions in Connection with Share Buy-back Program globenewswire.com - April 2 at 3:24 AM
	Genmab A/S (NASDAQ:GMAB) Receives Buy Rating from HC Wainwright marketbeat.com - March 27 at 8:18 AM
	Genmab A/S (NASDAQ:GMAB) Shares Gap Up to $29.98 marketbeat.com - March 26 at 12:26 PM
	Morgan Stanley Reaffirms Underweight Rating for Genmab A/S (NASDAQ:GMAB) marketbeat.com - March 26 at 12:01 PM
	Transactions in Connection with Share Buy-back Program globenewswire.com - March 25 at 9:31 AM
	Genmab A/S ADR wsj.com - March 23 at 10:39 AM
	Genmab A/S (NASDAQ:GMAB) Given Average Recommendation of "Hold" by Analysts marketbeat.com - March 20 at 3:57 AM
	The 10 best dressed from the 2024 NAACP Image Awards nz.finance.yahoo.com - March 18 at 9:01 AM
	Completion of share buy-back program globenewswire.com - March 18 at 5:49 AM
	GMAB Apr 2024 30.000 put ca.finance.yahoo.com - March 15 at 11:44 PM
	Biogen chief medical officer departs, joins Alto Neuroscience board msn.com - March 15 at 6:43 PM
	Genmab To Repurchase Up To DKK 3.5 Bln Of Shares markets.businessinsider.com - March 15 at 1:42 PM
	Genmab Announces Initiation of Share Buy-Back Program globenewswire.com - March 15 at 8:16 AM
	Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons globenewswire.com - March 13 at 4:58 PM
	Constitution of the Board of Directors in Genmab A/S, Grant of Restricted Stock Units to Board Members and Employees and Grant of Warrants to Employees in Genmab globenewswire.com - March 13 at 4:53 PM
	BeiGene gains as access to leukemia drug Brukinsa expands seekingalpha.com - March 13 at 1:09 PM
	Transactions in connection with share buy-back program globenewswire.com - March 11 at 5:42 AM
	Northern Trust Corp Raises Stock Holdings in Genmab A/S (NASDAQ:GMAB) marketbeat.com - March 11 at 4:57 AM
	Royal London Asset Management Ltd. Invests $8.94 Million in Genmab A/S (NASDAQ:GMAB) marketbeat.com - March 10 at 7:33 AM
	Genmab A/S (NASDAQ:GMAB) Shares Sold by Qube Research & Technologies Ltd marketbeat.com - March 7 at 5:51 AM
	Genmab A/S (NASDAQ:GMAB) Earns "Buy" Rating from HC Wainwright marketbeat.com - March 6 at 8:25 AM
	Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons globenewswire.com - March 4 at 1:10 PM
	Schonfeld Strategic Advisors LLC Invests $8 Million in Genmab A/S (NASDAQ:GMAB) marketbeat.com - March 4 at 7:51 AM

Get Genmab A/S News Delivered to You Automatically

New crypto project uncovers 2,050% in 65 days (Ad)

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

GMAB Media Mentions By Week

GMAB Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GMAB
News Sentiment
▼
0.78

0.53
▲
Average
Medical
News Sentiment

GMAB News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GMAB Articles
This Week
▼
9

4
▲
GMAB Articles
Average Week

Get Genmab A/S News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:GMAB) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Genmab A/S (GMAB) News Today

GMAB Media Mentions By Week

GMAB Media Sentiment

GMAB News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info